IT has been recently revealed that mutations resulting in the loss of SPRED1 function occur in ∼ 2% of human cancers, and genetic removal of SPREDs leads to various phenotypes, such as behavioral issues, dwarfism, and increased susceptibility to leukemia in mice18. Here, SPRED1 is linked to cancer.